Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2021
Safety and Efficacy of Oral Human Parathyroid Hormone (1-34) in Hypoparathyroidism: An Open-Label StudySofia Ish-Shalom, Yoseph Caraco, Nariman Saba Khazen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2017
Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy VolunteersMichal Abraham, Yaron Pereg, Baruch Bulvik, et al.Neurology|May 1, 2019
A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathyHanns Lochmüller, Anthony Behin, Yoseph Caraco, et al.Med (New York, N.Y.)|June 21, 2025
A phase 3, randomized trial to evaluate lot-to-lot consistency of V116, an adult-specific pneumococcal conjugate vaccine (STRIDE-4)Paul Scott, Benita Ukkonen, Yoseph Caraco, et al.Pharmacology Research & Perspectives|December 20, 2022
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19Mohamad Shebley, Stanley Wang, Izna Ali, et al.Journal of Translational Medicine|February 15, 2023
Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial resultsMarc Gotkine, Yoseph Caraco, Yossef Lerner, et al.Vaccines|May 7, 2025
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10)Veronika Jotterand, Vinita Jagannath, Andrea Accini Diaz, et al.Journal of Clinical Neuromuscular Disease|August 23, 2017
Characterization of Strength and Function in Ambulatory Adults With GNE MyopathyZohar Argov, Faye Bronstein, Alicia Esposito, et al.Clinical Trials (London, England)|March 3, 2025
Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT studyYoseph Caraco, Matthew G Johnson, Joseph A Chiarappa, et al.NEJM Evidence|February 6, 2024
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized AdultsYoseph Caraco, Gordon E Crofoot, Pablo Andres Moncada, et al.Pageof 5